Phase 4 Parkinson's Disease Trial, Recruiting (NCT06013956)

Phase 4 Parkinson's Disease Trial, Recruiting NCT06013956 Sponsor: David Escobar Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06013956 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are able to give informed consent to participate in research.
People who have been clinically diagnosed with idiopathic Parkinson's disease (Parkinson's disease without a known external cause).
People whose doctor has determined, through standard medical assessment, that they are a suitable candidate for a type of brain surgery called deep brain stimulation (DBS), targeting a specific area of the brain called the subthalamic nucleus.
People who are able to wait a short period before taking their regular daily Parkinson's disease medications when required.

Who may not be able to join:

People who have a form of Parkinsonism caused by another condition, or who have had a stroke, or who have a progressive brain or nervous system disease other than Parkinson's disease.
People who have a medical condition that, in the opinion of the research team, could significantly increase health risks, interfere with following the study requirements, or affect the study results.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 216-390-1907

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06013956

Sponsor: David Escobar

Phase: Phase 4

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 216-390-1907

More information: https://clinicaltrials.gov/study/NCT06013956

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are able to give informed consent to participate in research.
People who have been clinically diagnosed with idiopathic Parkinson's disease (Parkinson's disease without a known external cause).
People whose doctor has determined, through standard medical assessment, that they are a suitable candidate for a type of brain surgery called deep brain stimulation (DBS), targeting a specific area of the brain called the subthalamic nucleus.
People who are able to wait a short period before taking their regular daily Parkinson's disease medications when required.

Who may not be able to join:

People who have a form of Parkinsonism caused by another condition, or who have had a stroke, or who have a progressive brain or nervous system disease other than Parkinson's disease.
People who have a medical condition that, in the opinion of the research team, could significantly increase health risks, interfere with following the study requirements, or affect the study results.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

David Escobar

Registry

ClinicalTrials.gov

Start date

29 August 2023

Est. completion

30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Effect of eiDBS suppression vs. off-stimulation on finger tapping speed; Effect of eiDBS amplification vs. off-stimulation on finger tapping speed; Effect of eiDBS suppression vs. off-stimulation on forearm speed; Effect of eiDBS amplification vs. off-stimulation on forearm speed; Effect of eiDBS suppression vs. off-stimulation on UPDRS-III rigidity subscore; Effect of eiDBS amplification vs. off-stimulation on UPDRS-III rigidity subscore; Correlation between levodopa-related changes in finger tapping speed and the amplitude of stimulation-evoked beta oscillations; Correlation between levodopa...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov